Clearing the Path: Exploring Apoptotic Cell Clearance in Inflammatory and Autoimmune Disorders for Therapeutic Advancements.
Shadi GhorbanzadehJavad Yaghmoorian KhojiniReza AboualiSajad AlimardanMohammad ZahediZahra TahershamsiAmir TajbakhshSeyed Mohammad GheibihayatPublished in: Molecular biotechnology (2024)
Inflammatory and autoimmune disorders, characterized by dysregulated immune responses leading to tissue damage and chronic inflammation, present significant health challenges. This review uniquely focuses on efferocytosis-the phagocyte-mediated clearance of apoptotic cells-and its pivotal role in these disorders. We delve into the intricate mechanisms of efferocytosis' four stages and their implications in disease pathogenesis, distinguishing our study from previous literature. Our findings highlight impaired efferocytosis in conditions like atherosclerosis and asthma, proposing its targeting as a novel therapeutic strategy. We discuss the therapeutic potential of efferocytosis in modulating immune responses and resolving inflammation, offering a new perspective in treating inflammatory disorders.
Keyphrases
- oxidative stress
- immune response
- induced apoptosis
- cell death
- multiple sclerosis
- healthcare
- systematic review
- public health
- cardiovascular disease
- chronic obstructive pulmonary disease
- mental health
- single cell
- stem cells
- dendritic cells
- toll like receptor
- drug induced
- cell therapy
- cancer therapy
- drug delivery
- cystic fibrosis
- inflammatory response
- human health
- allergic rhinitis